JPMORGAN CHASE & CO - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 49 filers reported holding ATYR PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2017$105,000
+1066.7%
30,115
+1573.1%
0.00%
Q3 2017$9,000
-92.5%
1,800
-95.8%
0.00%
Q2 2016$120,000
-91.8%
43,222
-88.4%
0.00%
Q1 2016$1,469,000
-60.2%
372,850
-0.8%
0.00%
-100.0%
Q4 2015$3,694,000
-1.1%
375,750
+3.2%
0.00%0.0%
Q3 2015$3,736,000
+8.3%
364,173
+95.5%
0.00%0.0%
Q2 2015$3,449,000186,2490.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$18,755,00012.78%
EcoR1 Capital, LLC 840,462$8,623,0003.92%
Rock Springs Capital Management LP 388,996$3,991,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 209,027$2,145,0000.27%
Baker Brothers Advisors 2,335,125$23,958,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$4,735,0000.18%
TIVERTON ASSET MANAGEMENT LLC 472,236$4,845,0000.11%
RS INVESTMENT MANAGEMENT CO LLC 1,082,249$11,104,0000.10%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$4,262,0000.07%
Magnetar Financial LLC 354,659$3,639,0000.05%
View complete list of ATYR PHARMA INC shareholders